These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 29783016)
21. Effect on multifocal electroretinogram in persistently elevated intraocular pressure by erigeron breviscapus extract. Lu XJ; Zhang FW; Cheng L; Liu AQ; Duan JG Int J Ophthalmol; 2011; 4(4):349-52. PubMed ID: 22553678 [TBL] [Abstract][Full Text] [Related]
22. Delineation of Platelet Activation Pathway of Scutellarein Revealed Its Intracellular Target as Protein Kinase C. Tian X; Chang L; Ma G; Wang T; Lv M; Wang Z; Chen L; Wang Y; Gao X; Zhu Y Biol Pharm Bull; 2016; 39(2):181-91. PubMed ID: 26581323 [TBL] [Abstract][Full Text] [Related]
23. Separation of scutellarin from crude extracts of Erigeron breviscapus (vant.) Hand. Mazz. by macroporous resins. Gao M; Huang W; Liu CZ J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):22-6. PubMed ID: 17704013 [TBL] [Abstract][Full Text] [Related]
24. Sulfur fertiliser enhancement of Erigeron breviscapus (Asteraceae) quality by improving plant physiological responses and reducing soil cadmium bioavailability. Liu Y; Liu Y; Chen Y; Zhao P; Yang S; He S; Long G Environ Sci Pollut Res Int; 2022 Oct; 29(46):70508-70519. PubMed ID: 35585458 [TBL] [Abstract][Full Text] [Related]
25. In-line monitoring of extraction process of scutellarein from Erigeron breviscapus (vant.) Hand-Mazz based on qualitative and quantitative uses of near-infrared spectroscopy. Wu Y; Jin Y; Ding H; Luan L; Chen Y; Liu X Spectrochim Acta A Mol Biomol Spectrosc; 2011 Sep; 79(5):934-9. PubMed ID: 21561801 [TBL] [Abstract][Full Text] [Related]
26. Development of a stable genetic transformation system in Erigeron breviscapus: a case study with EbYUC2 in relation to leaf number and flowering time. Zhu Q; Lu YC; Xiong JL; Yang YH; Yang JL; Yang SC; Zhang GH; Sha BC; He SM Planta; 2024 Mar; 259(5):98. PubMed ID: 38522041 [TBL] [Abstract][Full Text] [Related]
27. Rapid and Efficient Optimization Method for a Genetic Transformation System of Medicinal Plants Zhao Y; Yu Y; Guo J; Zhang Y; Huang L Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982685 [No Abstract] [Full Text] [Related]
28. [Study on effects of Erigeron breviscapus extract on anticoagulation]. Wang Y; Yang X; Liu H; Tang X Zhong Yao Cai; 2003 Sep; 26(9):656-8. PubMed ID: 14692325 [TBL] [Abstract][Full Text] [Related]
29. Exploring the neuroprotection of the combination of astragaloside A, chlorogenic acid and scutellarin in treating chronic cerebral ischemia via network analysis and experimental validation. Cheng F; Zhang J; Yang P; Chen Z; Fu Y; Mi J; Xie X; Liu S; Sheng Y Heliyon; 2024 Apr; 10(8):e29162. PubMed ID: 38655299 [TBL] [Abstract][Full Text] [Related]
30. Systematic Investigation of Ginkgo Biloba Leaves for Treating Cardio-cerebrovascular Diseases in an Animal Model. Yang Y; Li Y; Wang J; Sun K; Tao W; Wang Z; Xiao W; Pan Y; Zhang S; Wang Y ACS Chem Biol; 2017 May; 12(5):1363-1372. PubMed ID: 28333443 [TBL] [Abstract][Full Text] [Related]
31. Metabolic and pharmacokinetic studies of scutellarin in rat plasma, urine, and feces. Xing JF; You HS; Dong YL; Lu J; Chen SY; Zhu HF; Dong Q; Wang MY; Dong WH Acta Pharmacol Sin; 2011 May; 32(5):655-63. PubMed ID: 21516133 [TBL] [Abstract][Full Text] [Related]
32. [Cloning and bioinformation analysis of flavone synthase II gene of Erigeron breviscapus]. Zhang GH; Li CT; Wang JJ; Zhang W; Chen JW; Yang JW; Yang SC Zhongguo Zhong Yao Za Zhi; 2013 Jul; 38(14):2231-6. PubMed ID: 24199545 [TBL] [Abstract][Full Text] [Related]
33. Neuroprotection of Scutellarin is mediated by inhibition of microglial inflammatory activation. Wang S; Wang H; Guo H; Kang L; Gao X; Hu L Neuroscience; 2011 Jun; 185():150-60. PubMed ID: 21524691 [TBL] [Abstract][Full Text] [Related]
34. Systems Pharmacology Dissection of Multiscale Mechanisms of Action for Herbal Medicines in Treating Rheumatoid Arthritis. Wang J; Li Y; Yang Y; Du J; Zhao M; Lin F; Zhang S; Wang B Mol Pharm; 2017 Sep; 14(9):3201-3217. PubMed ID: 28771010 [TBL] [Abstract][Full Text] [Related]
35. Two-step purification of scutellarin from Erigeron breviscapus (vant.) Hand. Mazz. by high-speed counter-current chromatography. Gao M; Gu M; Liu CZ J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jul; 838(2):139-43. PubMed ID: 16790369 [TBL] [Abstract][Full Text] [Related]
36. Network pharmacology-based prediction of active compounds and molecular targets in Yijin-Tang acting on hyperlipidaemia and atherosclerosis. Lee AY; Park W; Kang TW; Cha MH; Chun JM J Ethnopharmacol; 2018 Jul; 221():151-159. PubMed ID: 29698773 [TBL] [Abstract][Full Text] [Related]
37. [FTIR spectra-principal component analysis of Erigeron breviscapus and Erigeron multiradiatus from different areas]. Zhang ZF; Liu Y; Zhang H Guang Pu Xue Yu Guang Pu Fen Xi; 2009 Dec; 29(12):3263-6. PubMed ID: 20210146 [TBL] [Abstract][Full Text] [Related]
38. Synthesis of Scutellarein Derivatives with a Long Aliphatic Chain and Their Biological Evaluation against Human Cancer Cells. Ni G; Tang Y; Li M; He Y; Rao G Molecules; 2018 Feb; 23(2):. PubMed ID: 29389889 [TBL] [Abstract][Full Text] [Related]
39. Dong X; Qu S Front Pharmacol; 2022; 13():877872. PubMed ID: 35559239 [TBL] [Abstract][Full Text] [Related]
40. Two new constituents from Erigeron breviscapus. Li J; Yu DQ J Asian Nat Prod Res; 2013 Sep; 15(9):969-73. PubMed ID: 24073637 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]